Talor; Eyal

Patent Applications and Registrations

Patent applications and USPTO patent grants for Talor; Eyal.The latest application filed is for "methods of preparation and composition of peptide constructs useful for treatment of rheumatoid arthritis".

Company Profile

4.5.9

Talor; Eyal - Baltimore MD US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for inducing an immune response and formulations thereof Grant 10,179,174 - Zimmerman , et al. Ja	2019-01-15
Method for inducing an immune response for treatment of cancer and autoimmune diseases or conditions Grant 10,179,164 - Zimmerman , et al. Ja	2019-01-15
Methods Of Preparation And Composition Of Peptide Constructs Useful For Treatment Of Rheumatoid Arthritis App 20160158330 - Zimmerman; Daniel H. ; et al.	2016-06-09
Method For Inducing An Immune Response And Formulations Thereof App 20150140065 - Zimmerman; Daniel H. ; et al.	2015-05-21
Method For Inducing An Immune Response For Treatment Of Cancer And Autoimmune Diseases Or Conditions App 20140286858 - Zimmerman; Daniel H. ; et al.	2014-09-25
Method For Modulating Hla Class Ii Tumor Cell Surface Expression With A Cytokine Mixture App 20070166279 - Talor; Eyal	2007-07-19
Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture App 20050163749 - Talor, Eyal	2005-07-28
Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture App 20050158275 - Talor, Eyal	2005-07-21
Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture Grant 6,896,879 - Talor May 24, 2	2005-05-24
Method of pre-sensitizing cancer prior to treament with radiation and/or chemotherapy and a novel cytokine mixture App 20050002899 - Talor, Eyal	2005-01-06
Method of pre-sensitizing cancer prior to treatment with radiation and/or chemotherapy and a novel cytokine mixture App 20050002896 - Talor, Eyal	2005-01-06

Company Registrations

SEC

0001238028

TALOR EYAL

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.